StockData

Research Alliance Corp III (RACC) stock

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.07−0.05 (-0.49%)

Close on Nov 18, 2026Market cap $91.62MP/E –Yield –

Research Alliance Corp III revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Research Alliance Corp III

Research Alliance Corp III has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Research Alliance Corp III figures

See a number that looks wrong?